2 completed, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Unknown 1 |
Follow Dumping Syndrome: new trials by email Literature Review of Dumping Syndrome trials Research Report on Dumping Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Empagliflozin 25 MG, Placebo - Dumping Syndrome, Hypoglycemia, Reactive | Phase 4 | Completed | Insel Gruppe AG, University Hospital Bern | 22 | 2021-12-01 | 2023-03-14 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Treatment of the Dumping Syndrome With Lanreotide Autogel® Somatuline (Lanreotide Autogel®) - Dumping Syndrome | Phase 4 | Unknown | Radboud University Medical Center | 2007-10-01 | 2007-10-12 |
Acromegaly (1) · Hypoglycemia (1) · Melanoma (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Pituitary ACTH Hypersecretion (1) · Pituitary Neoplasms (1) · Prostatic Neoplasms (1)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Postgastrectomy Syndromes (3) · Postoperative Complications (3) · Stomach Diseases (3) · Bone Diseases (1) · Bone Diseases, Endocrine (1) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Cabergoline (1) · empagliflozin (1) · lanreotide (1) · pasireotide (1)
Insel Gruppe AG, University Hospital Bern (1) · RECORDATI GROUP (1) · Radboud University Medical Center (1)
Netherlands (2) · Switzerland (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1)